tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Trevi Therapeutics Inc

TRVI
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
13.810USD
+0.290+2.14%
์ข…๊ฐ€ย 10-29 16:00๏ผˆET๏ผ‰
1.97B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

TRVI ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Trevi Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ
์‹œ๊ฐ€์ด์•ก
1.97B
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-43.19
์ฃผ๋‹น์ˆœ์ด์ต
-0.32
์ˆ˜์ต
--
์ˆœ์ด์ต
-47.91M
ROE
-33.59%
ROA
-31.83%
Trevi Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜
์ตœ์‹  ์ถœ์‹œ
Aug 6, 2026
EPS / ์˜ˆ์ƒ
-0.11/-0.11
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-20.42%-0.11
-3.06%-0.09
46.95%-0.06
37.79%-0.08
22.81%-0.09
19.74%-0.09
-36.94%-0.11
-68.70%-0.13
-68.88%-0.12
-68.77%-0.11
7.83%-0.08
---0.08
---0.07
---0.06
---0.09
---0.44
----
----
----
----
์ˆœ์ด์ต
-44.68%-17.80M
-27.58%-13.19M
27.15%-8.32M
10.87%-11.80M
0.41%-12.30M
5.16%-10.34M
-45.95%-11.41M
-72.02%-13.24M
-72.88%-12.35M
-70.32%-10.90M
-42.07%-7.82M
6.87%-7.70M
11.26%-7.14M
12.66%-6.40M
35.39%-5.50M
-13.94%-8.27M
17.79%-8.05M
12.45%-7.33M
10.53%-8.52M
1.67%-7.25M
๋ถ€์ฑ„๋น„์œจ
----
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-83.67%0.03%
-52.85%0.09%
-40.27%0.13%
-97.63%0.16%
-97.70%0.17%
--0.19%
--0.21%
--6.65%
--7.44%
--8.41%
----
----
----
----
์˜์—… ์ด์ต
-49.46%-20.51M
-30.01%-14.91M
16.52%-10.22M
1.21%-13.92M
-3.26%-13.72M
3.66%-11.47M
-37.05%-12.24M
-55.74%-14.09M
-58.54%-13.29M
-57.42%-11.91M
-34.19%-8.93M
-7.61%-9.04M
-7.19%-8.38M
-7.66%-7.56M
19.53%-6.66M
-20.99%-8.40M
14.69%-7.82M
13.15%-7.03M
10.01%-8.27M
4.10%-6.95M
์ˆœ์ด์ต
-44.68%-17.80M
-27.58%-13.19M
27.15%-8.32M
10.87%-11.80M
0.41%-12.30M
5.16%-10.34M
-45.95%-11.41M
-72.02%-13.24M
-72.88%-12.35M
-70.32%-10.90M
-42.07%-7.82M
6.87%-7.70M
11.26%-7.14M
12.66%-6.40M
35.39%-5.50M
-13.94%-8.27M
17.79%-8.05M
12.45%-7.33M
10.53%-8.52M
1.67%-7.25M
์œ ๋™์ž์‚ฐ
57.17%325.70M
66.75%176.12M
75.14%191.66M
194.49%198.30M
187.30%207.23M
37.59%105.62M
24.99%109.43M
-28.33%67.34M
-27.30%72.13M
-32.78%76.77M
-28.60%87.55M
-26.21%93.95M
24.19%99.21M
282.72%114.20M
223.04%122.62M
314.62%127.32M
107.60%79.89M
-29.22%29.84M
-17.96%37.96M
-44.38%30.71M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-5.46%8.74M
3.63%7.12M
-7.23%9.75M
-0.90%9.04M
36.86%9.24M
30.14%6.87M
80.44%10.51M
76.36%9.12M
43.32%6.75M
-60.03%5.28M
-56.54%5.82M
-64.67%5.17M
-69.47%4.71M
2.60%13.20M
5.31%13.40M
47.69%14.64M
64.01%15.43M
141.05%12.87M
129.05%12.72M
62.43%9.91M
์ด ์ž์‚ฐ
58.64%330.52M
67.85%179.61M
74.43%193.44M
189.31%199.36M
182.26%208.34M
36.21%107.00M
24.05%110.90M
-28.14%68.91M
-26.90%73.81M
-32.40%78.56M
-27.32%89.40M
-25.29%95.90M
24.03%100.98M
282.43%116.20M
219.73%123.02M
306.26%128.36M
107.96%81.41M
-29.11%30.39M
-18.37%38.48M
-43.46%31.60M
๋ถ€์ฑ„ ์ด๊ณ„
-8.47%9.01M
-0.90%7.48M
-9.43%10.20M
-3.73%9.57M
28.94%9.85M
21.24%7.55M
64.18%11.26M
58.11%9.94M
29.34%7.64M
-56.99%6.22M
-55.93%6.86M
-65.94%6.29M
-71.75%5.90M
-27.36%14.47M
-27.31%15.56M
-8.70%18.46M
-2.40%20.90M
3.88%19.92M
7.81%21.40M
-0.22%20.22M
์ž๋ณธ ์ด๊ณ„
61.97%321.51M
73.07%172.13M
83.90%183.24M
221.84%189.79M
199.96%198.49M
37.50%99.46M
20.71%99.64M
-34.19%58.97M
-30.40%66.17M
-28.90%72.33M
-23.18%82.55M
-18.46%89.61M
57.11%95.07M
872.30%101.73M
529.34%107.46M
865.76%109.90M
241.20%60.52M
-55.82%10.46M
-37.41%17.07M
-68.05%11.38M
์ˆœ์˜์—…์ด์ต
-72.55%-17.43M
-23.83%-16.69M
20.09%-7.63M
-13.86%-10.88M
-16.33%-10.10M
-28.76%-13.48M
-50.18%-9.55M
-31.28%-9.56M
12.07%-8.68M
-27.69%-10.47M
-0.44%-6.36M
15.12%-7.28M
-59.89%-9.88M
-15.58%-8.20M
-1.64%-6.33M
-18.44%-8.58M
21.80%-6.18M
6.41%-7.09M
30.20%-6.23M
-3.93%-7.24M
์ˆœํˆฌ์ž
-4192.64%-112.04M
270.49%16.96M
-28.22%-30.61M
-764.38%-50.94M
-194.29%-2.61M
-22.99%-9.95M
-285.85%-23.87M
-57.36%7.67M
-85.91%2.77M
-190.28%-8.09M
126.59%12.85M
470.76%17.98M
136.22%19.64M
--8.96M
---48.31M
---4.85M
---54.22M
----
100.00%0.00
100.00%0.00
์ˆœ์žฌ๋ฌดํ™œ๋™
48.88%164.36M
-97.45%222.00K
-99.45%284.00K
-67.28%1.63M
2078.71%110.39M
31189.29%8.71M
95409.26%51.47M
229.67%4.98M
166.12%5.07M
98.36%-28.00K
-108.28%-54.00K
-97.27%1.51M
-113.69%-7.66M
-172.48%-1.70M
-95.26%652.00K
41170.15%55.30M
1933.35%55.98M
-115.07%-625.00K
2057.14%13.74M
-99.17%134.00K

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Trevi Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 191.66M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 75.14์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Trevi Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 193.44M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 74.43์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Trevi Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 10.20M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -9.43์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Trevi Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 183.24M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 83.90์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Trevi Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -49.33M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 4.26์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Trevi Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” -94.11M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -337.14์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Trevi Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 121.01M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 96.82์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -0.32์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 32.46์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -42.76M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 10.75์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -30.23์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 42.52์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -28.10์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 41.26์ž…๋‹ˆ๋‹ค.

Trevi Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Trevi Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -49.33M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 4.26์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ